LISA WALLACE: Open Payments
NPI 1013349000 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $188 |
| GENZYME CORPORATION | 1 | $114 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Insmed, Inc. | 1 | $26 |
Products named: DUPIXENT, FASENRA, ZERBAXA, WINREVAIR, Arikayce, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
